An Adolescent Patient With Idiopathic Pulmonary Arterial Hypertension Weaned Off Intravenous Epoprostenol Following Treatment With Selexipag: A Case Report

Idiopathic pulmonary arterial hypertension (PAH) is a rare, progressive disease affecting the pulmonary arteries. Epoprostenol, a synthetic prostaglandin analog, is the most potent pharmacological treatment modality used in patients with PAH. However, it requires continuous intravenous infusion, whi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chida-Nagai, Ayako, Tsujioka, Takao, Sasaki, Daisuke, Izumi, Gaku, Yamazawa, Hirokuni, Takeda, Atsuhito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247454/
https://www.ncbi.nlm.nih.gov/pubmed/35783314
http://dx.doi.org/10.3389/fped.2022.909595

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247454/
https://www.ncbi.nlm.nih.gov/pubmed/35783314
http://dx.doi.org/10.3389/fped.2022.909595

Ejemplares similares